TickerFactsScreenerDevelopers

NovoCure Ltd (NVCR) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2012: $49.42M2013: $171.78M2014: $97.88M2015: $250.82M2016: $142.34M2017: $113.56M2018: $112.26M2019: $217.79M2020: $476.53M2021: $410.49M2022: $441.17M2023: $362.50M2024: $360.18M2025: $340.47M$340.47M
2012Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$340.47M-5.5%
2024$360.18M-0.6%
2023$362.50M-17.8%
2022$441.17M+7.5%
2021$410.49M-13.9%
2020$476.53M+118.8%
2019$217.79M+94.0%
2018$112.26M-1.1%
2017$113.56M-20.2%
2016$142.34M-43.2%
2015$250.82M+156.3%
2014$97.88M-43.0%
2013$171.78M+247.6%
2012$49.42M—